Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Open Access Highly Access Email this article to a friend

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Sacha J Howell*, Elizabeth Anderson, Tom Hunter, Gillian Farnie and Robert B Clarke

Breast Cancer Research 2008, 10:R68 doi:10.1186/bcr2129

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.